Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yogesh Rathore
Observed name:
Y. Rathore
Institution:
Post Graduate Institute of Medical Education and Research
Observed institution:
Post Graduate Institute of Medical Education and Research
ORCID:
0000-0001-5664-1323
Observed ORCID:
0000-0001-5664-1323
OpenAlex ID:
A5038259794
Noninvasive treatment of keloid using customized Re-188 skin patch
2017
·
Priya Bhusari
, Jaya Shukla
, et al.
·
Dermatologic Therapy
·
21
Targeting Breast Cancer Using 177Lu-Labeled Trastuzumab and Trastuzumab Fragment: First-in-Human Clinical Experience
2024
·
Yogesh Rathore
, Tamanna Lakhanpal
, et al.
·
Clinical Nuclear Medicine
·
9
Cold kit for Rhenium-188 microspheres based selective intra-arterial therapy (SIRT): Preparation, characterization and feasibility study
2022
·
Jaya Shukla
, Ankita Goyal
, et al.
·
Applied Radiation and Isotopes
·
8
Re-Rechallenge 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer: A Step Further
2024
·
Piyush Aggarwal
, Vinisha Gunasekaran
, et al.
·
Clinical Nuclear Medicine
·
6
Concentration protocol of rhenium-188 perrhenate eluted from tungsten-188/rhenium-188 generator for the preparation of high-yield rhenium-188-labelled radiopharmaceuticals
2018
·
Anupriya Chhabra
, Yogesh Rathore
, et al.
·
Nuclear Medicine Communications
·
5
Freeze-dried microspheres for selective intra-arterial radionuclide therapy: an affordable solution
2020
·
Jaya Shukla
, Naveen Kalra
, et al.
·
Nuclear Medicine Communications
·
4
Exploring currently available fibroblast activation protein targeting molecules in adrenocortical carcinoma: Navigating theranostic pathways
2025
·
Sejal Chopra
, Jaya Shukla
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
3
28P Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu-expressing breast cancer patients
2022
·
Y. Rathore
, J. Shukla
, et al.
·
Annals of Oncology
·
2
Abstract A10: Radiolabelled AMD3100 for the management of malignant lymphoma: Translational study
2022
·
Tamanna Lakhanpal
, Jaya Shukla
, et al.
·
Blood Cancer Discovery
·
2
Bifunctional chelator-plerixafor complex for targeting CXCR4 receptors: radiolabeling, in-vitro, and preclinical study
2025
·
Tamanna Lakhanpal
, Jaya Shukla
, et al.
·
Nuclear Medicine Communications
·
1
40P Development of radiolabelled plerixafor as a theranostic molecule for targeting CXCR4 receptor expressing cancers: A translational study
2023
·
T. Lakhanpal
, B.R. Mittal
, et al.
·
ESMO Open
·
1
PDF
35P Exploring plerixafor as a vector molecule in nuclear medicine for targeting CXCR4 receptor overexpression in vivo
2022
·
T. Lakhanpal
, J. Shukla
, et al.
·
Annals of Oncology
·
1
PDF
80P Radiolabelled trastuzumab Fab as a theranostic molecule for HER2 positive breast cancers
2021
·
Y. Rathore
, J. Shukla
, et al.
·
Annals of Oncology
·
1
The potential of trastuzumab Fab-DTPA as a vehicle molecule for theranostic application in HER2 receptor expressing cancers
2020
·
Yogesh Rathore
, Jaya Shukla
, et al.
·
Journal of Nuclear Medicine
·
1
Conjugation of DOTAGA and NOTA with Duramycin for radiolabeling with Ga-68 for its future use in apoptosis imaging
2020
·
Gurvinder Kaur
, Jaya Shukla
, et al.
·
Journal of Nuclear Medicine
·
1
Internal Radiation Dosimetry Studies Using Radiolabelled 177Lu-cyclic Pentapeptide in Patients with Chemotherapy-Refractory Non-Hodgkin’s Lymphoma
2026
·
Tamanna Lakhanpal
, Yogesh Rathore
, et al.
·
IntechOpen eBooks
PDF
188Re-SIRT Cold Kit: A Promising and Affordable Solution for Hepatocellular Carcinoma
2026
·
Sejal Chopra
, Naveen Kalra
, et al.
·
Proceedings of the National Academy of Sciences India Section B Biological Sciences
Potential role of 68Ga- and 177Lu-cyclic pentapeptides for in-vivo targeting CXCR4 receptor expression in chemotherapy relapse MCL patient.
2026
·
Tamanna Lakhanpal
, Bhagwant Rai Mittal
, et al.
·
PubMed Central
PDF
Abstract B043: Radiolabelled Trastuzumab Fab as a theranostic agent for HER2 expressing breast cancer
2024
·
Jaya Shukla
, Yogesh Rathore
, et al.
·
Cancer Research
636P Development of radiolabelled plerixafor as a theranostic tool for malignant lymphomas
2022
·
T. Lakhanpal
, J. Shukla
, et al.
·
Annals of Oncology
PDF
Ga-68 labeled Trastuzumab Fab for imaging HER2 positive lesions: formulation and characterization.
2018
·
Yogesh Rathore
, Jaya Shukla
, et al.
Show more works
View as search
Works count:
21
Citation count:
66
H-index:
5
I10-index:
1
Year
Topic
Type